Literature DB >> 24535425

Classic and current opinion in embryonic organ transplantation.

Marc R Hammerman1.   

Abstract

PURPOSE OF REVIEW: Here, we review the rationale for the use of organs from embryonic donors, antecedent investigations and recent work from our own laboratory, exploring the utility for transplantation of embryonic kidney and pancreas as an organ replacement therapy. RECENT
FINDINGS: Ultrastructurally precise kidneys differentiate in situ in rats following xenotransplantation in mesentery of embryonic pig renal primordia. The developing organ attracts its blood supply from the host. Engraftment of pig renal primordia requires host immune suppression. However, beta cells originating from embryonic pig pancreas obtained very early following initiation of organogenesis [embryonic day 28 (E28)] engraft long term in nonimmune-suppressed diabetic rats or rhesus macaques. Engraftment of morphologically similar cells originating from adult porcine islets of Langerhans occurs in animals previously transplanted with E28 pig pancreatic primordia.
SUMMARY: Organ primordia engraft, attract a host vasculature and differentiate following transplantation to ectopic sites. Attempts have been made to exploit these characteristics to achieve clinically relevant endpoints for end-stage renal disease and diabetes mellitus using animal models. We and others have focused on use of the embryonic pig as a donor.

Entities:  

Mesh:

Year:  2014        PMID: 24535425      PMCID: PMC4094307          DOI: 10.1097/MOT.0000000000000054

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  24 in total

1.  Attributes of embryonic tissues after growth and development in heterologous hosts.

Authors:  H S GREENE
Journal:  Cancer Res       Date:  1955-03       Impact factor: 12.701

2.  Transplantation of normal embryonic tissues.

Authors:  M E RAWLES
Journal:  Ann N Y Acad Sci       Date:  1952-08-08       Impact factor: 5.691

Review 3.  Organogenetic tolerance.

Authors:  Marc R Hammerman
Journal:  Organogenesis       Date:  2010 Oct-Dec       Impact factor: 2.500

4.  Xenotransplantation of embryonic pig pancreas for treatment of diabetes mellitus in non-human primates.

Authors:  Marc R Hammerman
Journal:  J Biomed Sci Eng       Date:  2013-05-01

5.  Glucose tolerance normalization following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic ZDF rats.

Authors:  Sharon A Rogers; Feng Chen; Mike Talcott; Helen Liapis; Marc R Hammerman
Journal:  Transpl Immunol       Date:  2006-09-07       Impact factor: 1.708

6.  Transplantation of metanephroi across the major histocompatibility complex in rats.

Authors:  S A Rogers; H Liapis; M R Hammerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-01       Impact factor: 3.619

7.  Normalization of glucose post-transplantation into diabetic rats of pig pancreatic primordia preserved in vitro.

Authors:  Sharon A Rogers; Marc R Hammerman
Journal:  Organogenesis       Date:  2008-01       Impact factor: 2.500

8.  Chick embryo pancreatic transplants reverse experimental diabetes of rats.

Authors:  R Eloy; K Haffen; M Kedinger; J F Grenier
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

Review 9.  Transplantation of renal primordia: renal organogenesis.

Authors:  Marc R Hammerman
Journal:  Pediatr Nephrol       Date:  2007-08-01       Impact factor: 3.714

10.  Intraperitoneal transplantation of pancreatic anlagen.

Authors:  Sharon A Rogers; Helen Liapis; Marc R Hammerman
Journal:  ASAIO J       Date:  2003 Sep-Oct       Impact factor: 2.872

View more
  2 in total

Review 1.  Current Bioengineering and Regenerative Strategies for the Generation of Kidney Grafts on Demand.

Authors:  Ximo García-Domínguez; Jose S Vicente; Cesar D Vera-Donoso; Francisco Marco-Jimenez
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

2.  Underpinnings of cellular organ replacement therapies.

Authors:  Marc R Hammerman
Journal:  Curr Opin Organ Transplant       Date:  2014-04       Impact factor: 2.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.